Patrys Limited has released a press release.
Investor Presentation - TechKnow Invest Roadshow
Earlier from Patrys
- Appendix 4C - Quarterly - 30 June 2026
- Patrys Secures 50% Revenue Share in IP Commercialisation
- Patrys advances RLS-2202 toward Phase 1 Clinical Trial
- Appendix 4C - Quarterly - 31 March 2026